Graves' Orbitopathy and Anophthalmia.

Marta Pérez-López¹, Petros Perros²

¹Oftalmología, Unidad Cirugía Oculoplástica y Órbita, Hospital Universitario La Fe, Valencia, Spain.

²Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Abstract

BACKGROUND: Graves' orbitopathy (GO) affects approximately 0.1% of the population. GO in anophthalmic patients is extremely rare and may provide insights into the pathogenesis of this disease. METHODS: We describe four cases of GO in patients with previously acquired anophthalmia in one eye. RESULTS: In all cases, the anophthalmic eye showed both clinical and radiological evidence of GO. In two…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.